Your session is about to expire
← Back to Search
Other
Sperm Sorting for Gender Selection in Infertility Treatment
N/A
Recruiting
Led By Gianpiero Palermo, MD, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a method to choose sperm that will result in either a boy or a girl before fertilization. It targets couples undergoing infertility treatment. The process involves sorting sperm by density to identify male or female sperm, then using them for fertilization procedures like IVF or intrauterine insemination.
Who is the study for?
This trial is for couples undergoing infertility treatments like IVF or insemination who wish to select the gender of their offspring, whether for medical or non-medical reasons. Couples with severe male factor infertility cannot participate.
What is being tested?
The study tests a method to choose sperm based on desired gender before using them in standard fertility treatments such as in vitro fertilization (IVF) or intrauterine insemination.
What are the potential side effects?
Since the intervention involves standard fertility procedures, potential side effects may include discomfort from sperm collection and typical risks associated with IVF or insemination, like multiple pregnancies.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Sperm sortingExperimental Treatment1 Intervention
Selection of gender specific spermatozoa using a multilayer density gradient
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for infertility include ovulation induction, assisted reproductive technologies (ART) such as in vitro fertilization (IVF), and sperm retrieval techniques. Ovulation induction uses medications like clomiphene citrate or gonadotropins to stimulate the ovaries to produce eggs.
ART involves retrieving eggs and sperm, fertilizing them outside the body, and transferring the embryo back into the uterus. Sperm retrieval techniques, such as testicular sperm extraction (TESE), are used when men have low or no sperm in their ejaculate.
These treatments are crucial as they address specific causes of infertility, increasing the chances of conception. Gender-specific sperm selection, like density gradient separation, is a method used to select sperm carrying a specific sex chromosome, which can be used in ART to influence the gender of the offspring.
This matters for infertility patients as it provides more control over reproductive outcomes and can be particularly important for those with genetic concerns.
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,091 Previous Clinical Trials
1,152,746 Total Patients Enrolled
24 Trials studying Infertility
6,515 Patients Enrolled for Infertility
Gianpiero Palermo, MD, PhDPrincipal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
1,200 Total Patients Enrolled
1 Trials studying Infertility
1,200 Patients Enrolled for Infertility
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a significant fertility issue as a man.My partner and I are seeking IVF or insemination for gender selection.My partner and I are using IVF or insemination to choose our baby's gender.
Research Study Groups:
This trial has the following groups:- Group 1: Sperm sorting
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Infertility Patient Testimony for trial: Trial Name: NCT05500573 — N/A